← DEA Federal Register actions

Schedules of Controlled Substances: Placement of Metonitazene in Schedule I

scheduling · Rule · Final amendment; final order. · Published 2023-08-18 · 88 FR 56466

Document

Document number
2023-17778
Federal Register citation
88 FR 56466
Type
Rule
Action
Final amendment; final order.
Category
scheduling
Publication date
2023-08-18

Abstract

With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing N,N-diethyl- 2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. This scheduling action discharges the United States' obligations under the Single Convention on Narcotic Drugs (1961). This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle metonitazene.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown